catalpol has been researched along with Cerebral Ischemia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Xie, S; Zeng, B; Zhi, Y | 1 |
| Ren, H; Wang, H; Xu, X; Xue, Q; Yin, Y; Yu, S | 1 |
| Chen, S; Ruan, JC; Shan, CS; Xu, QQ; Yang, WT; Zheng, GQ; Zheng, XW | 1 |
| Liu, Y; Wang, HJ; Wu, JJ; Xu, XY; Yang, S | 1 |
| Lei, RY; Liu, YR; Lu, H; Wang, CE; Zhang, BA; Zhang, GB; Zhu, HC | 1 |
| Li, PW; Liu, YR; Lu, H; Sun, Y; Suo, JJ; Zhang, BA; Zhang, GB; Zhu, HC | 1 |
| Li, N; Tang, DD; Wang, LW; Xu, XY; Zhang, JF | 1 |
| An, LJ; Bao, YM; Duan, YL; Li, DQ; Liu, CP; Liu, Y | 1 |
| An, LJ; Bao, YM; Li, DQ; Li, Y; Liu, Y; Wang, CF | 1 |
1 review(s) available for catalpol and Cerebral Ischemia
| Article | Year |
|---|---|
Neuroprotection of Catalpol for Experimental Acute Focal Ischemic Stroke: Preclinical Evidence and Possible Mechanisms of Antioxidation, Anti-Inflammation, and Antiapoptosis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Brain Ischemia; Iridoid Glucosides; Neuroprotection; Stroke | 2017 |
8 other study(ies) available for catalpol and Cerebral Ischemia
| Article | Year |
|---|---|
Protective Effects of Catalpol on Limb Motor Function and Ultrastructure of Hippocampal Neurons in Rats with Cerebral Ischemia.
Topics: Animals; Brain Ischemia; Extremities; Hippocampus; Iridoid Glucosides; Male; Neurons; Neuroprotective Agents; Physical Conditioning, Animal; Rats, Sprague-Dawley | 2022 |
Catalpol protects vascular structure and promotes angiogenesis in cerebral ischemic rats by targeting HIF-1α/VEGF.
Topics: Animals; Brain; Brain Ischemia; Cells, Cultured; Endothelial Cells; Glucose; Hypoxia-Inducible Factor 1, alpha Subunit; Iridoid Glucosides; Male; Neovascularization, Physiologic; Oxygen; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2020 |
[Borneol promotes catalpol and puerarin crossing through blood-brain barrier in focal cerebral ischemic rats].
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Camphanes; Iridoid Glucosides; Isoflavones; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Receptors, Adrenergic, beta-2 | 2016 |
Effects of catalpol on ATPase and amino acids in gerbils with cerebral ischemia/reperfusion injury.
Topics: Adenosine Triphosphatases; Animals; Aspartic Acid; Brain Chemistry; Brain Ischemia; Carotid Artery, Common; Cell Membrane; Constriction; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Gerbillinae; Glutamic Acid; Iridoid Glucosides; Male; Models, Animal; Molecular Structure; Nerve Tissue Proteins; Neuroprotective Agents; Premedication; Reperfusion Injury; Single-Blind Method | 2014 |
Catalpol provides protective effects against cerebral ischaemia/reperfusion injury in gerbils.
Topics: Animals; Brain; Brain Ischemia; Calcitonin Gene-Related Peptide; Cerebral Infarction; Disease Models, Animal; Endothelin-1; Female; Free Radicals; Gerbillinae; Injections, Intraperitoneal; Iridoid Glucosides; Lipid Peroxidation; Male; Malondialdehyde; Neuropeptides; Oxidative Stress; Phytotherapy; Plant Extracts; Rehmannia; Reperfusion Injury; Stroke; Superoxide Dismutase | 2014 |
[Impact of drug molecules on HP-β-CD compound inclusion].
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Brain Ischemia; Camphanes; Drug Compounding; Freeze Drying; Iridoid Glucosides; Isoflavones; Solubility | 2014 |
Neuroprotection of catalpol in transient global ischemia in gerbils.
Topics: Animals; Apoptosis; Behavior, Animal; Brain Ischemia; Disease Models, Animal; Female; Gerbillinae; Glucosides; Glutathione Peroxidase; Hippocampus; In Situ Nick-End Labeling; Iridoid Glucosides; Iridoids; Lipid Peroxides; Male; Maze Learning; Neurons; Neuroprotective Agents; Nitric Oxide Synthase | 2004 |
Catalpol modulates the expressions of Bcl-2 and Bax and attenuates apoptosis in gerbils after ischemic injury.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain Infarction; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Drugs, Chinese Herbal; Female; Gene Expression Regulation, Enzymologic; Gerbillinae; Glucosides; Hippocampus; Immunohistochemistry; In Situ Nick-End Labeling; Iridoid Glucosides; Iridoids; Male; Nerve Degeneration; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Reperfusion Injury; Treatment Outcome | 2006 |